Skip to main content

Peer Review reports

From: Anastrozole for the prevention of breast cancer in high-risk postmenopausal women: cost-effectiveness analysis in the UK and the USA

Original Submission
27 Dec 2022 Submitted Original manuscript
17 Nov 2023 Reviewed Reviewer Report
4 Dec 2023 Reviewed Reviewer Report
27 Dec 2023 Author responded Author comments - Hong Sun
Resubmission - Version 2
27 Dec 2023 Submitted Manuscript version 2
28 Dec 2023 Author responded Author comments - Hong Sun
Resubmission - Version 3
28 Dec 2023 Submitted Manuscript version 3
25 Jan 2024 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
30 Jan 2024 Editorially accepted
13 Feb 2024 Article published 10.1186/s12913-024-10658-0

You can find further information about peer review here.

Back to article page